Search for Clinical Trial Results

Phosphorus Metabolism Disorders - 14 Studies Found
Status | Study |
Completed |
Study Name: Dietary Phosphate and Serum Phosphorus Condition: Phosphorus Metabolism Disorders Date: 2015-04-22 |
Not yet recruiting |
Study Name: The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis Condition: Hyperphosphatemia Date: 2017-05-21 Interventions:
|
Recruiting |
Study Name: Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices Condition:
Date: 2017-04-04 Interventions: |
Not yet recruiting |
Study Name: Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients Condition: Hyperphosphatemia Date: 2017-03-01 Interventions: Drug: Ferric Citrate One to two tablets of Ferric Citrate phosphorus binder administered by mouth before |
Recruiting |
Study Name: Behavioral Management of Phosphorus in Hemodialysis Patients Condition:
Date: 2016-10-17 Interventions:
|
Completed |
Study Name: The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients Condition: Hyperphosphatemia Date: 2013-05-04 Interventions: Drug: Mg Oxide 250 mg orally for 4 weeks Other Name: |
Recruiting |
Study Name: A Comparison of Lanthanum Carbonate and Calcium Carbonate in Children Condition: Hyperphosphatemia Date: 2012-09-26 Interventions:
|
Active, not recruiting |
Study Name: Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study Condition:
Date: 2012-04-13 Interventions:
|
Completed |
Study Name: Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) Condition:
Date: 2011-08-26 |
Active, not recruiting |
Study Name: Fosrenol Post-marketing Surveillance for Hemodialysis in Japan Condition: Hyperphosphatemia Date: 2011-08-17 Interventions: Drug: Lanthanum Carbonate (Fosrenol, BAY77-1931) - chewable tablet Patients in hemodialysis who have rec |